3rd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$450,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; enter for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4752 (119th), S. 3267 (119th), H.R. 6130 (119th), S. 2379 (119th), H.R. 3747 (119th)

Taxation/Internal Revenue Code TAX

Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Issues related to supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues related to pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2658 (119th)

Manufacturing MAN

Issues related to pharmaceutical manufacturing.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program; H.R.9599 Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act)

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9599 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.